Recent advancements in systems biology have been propelled by the increasing power of omics technologies—spanning genomics, transcriptomics, proteomics, ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer ...
News-Medical.Net on MSN
Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics
Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results